Shailaja Kasibhatla, PhD
Srinivasa R. Kasibhatla, PhD
Kumar V.Penmetsa, PhD
Sudhir Manda MD, FACP
Shailaja Kasibhatla, PhD
Srinivasa R. Kasibhatla, PhD
Kumar V.Penmetsa, PhD
Sudhir Manda MD, FACP
BioLara,
San Diego, CA 92120, USA.
© Copyright 2021 - BIOLARA
Dr. Kasibhatla, is the Vice President of Boundless Bio. She has more than 20 years of experience in the pharmaceutical industry and has contributed to the advancement of more than 10 programs towards clinical proof of concept. She served as Senior Director of Translational Development at Bristol-Myers Squibb (BMS) where she led the cohesive scientific, and strategic integration of early translational development across multiple protein degrader programs and managed these programs from preclinical to clinical proof of concept.
Dr. Srinivas R. Kasibhatla is currently the founder and CEO of Innovative Discovery Partners at San Diego, started by him in 2018, where he is a Pharmaceutical consultant working in the areas of medicinal chemistry, drug discovery project management, and intellectual property. He has over 25 years of drug discovery experience in multinational pharmaceuticals and small biotech companies across multiple therapeutic areas that include cancer, diabetes, obesity, Neuroscience, immunology, cardiovascular and infectious diseases. He has contributed to the discovery of 11 clinical candidates – cancer (4), diabetes (2), immunology (1), Neuroscience (1) and cardiovascular (2). He was the lead inventor or co-inventor on several issued and published patents.
Kumar Penmetsa has over 26 years of biotech and pharma industry experience. Kumar worked at Bristol-Myers Squibb Company for 15 years. During his time at BMS, Kumar managed R&D Operations functions in Oncology, Immunology, and Cardio-Metabolic diseases. Kumar also has consulting experience in biopharma R&D Strategy and Corporate Development. Kumar is currently a Senior Director, Global Development Consulting within the Clinical Research Group at Thermo Fisher Scientific. He graduated with a Ph.D. from N. C. State University, USA.
Dr. Manda is a Medical Oncologist& Hematologist at Arizona Oncology. Dr Manda is actively involved in both hematology and GI clinical trials through the US Oncology Network Research program. His areas of expertise are gastrointestinal cancers, which include colorectal, pancreatic, biliary, hepatocellular, gastric and esophageal cancers. He has a focused interest in the field of GI malignancies that includes detection and treatment of colorectal and other gastrointestinal neoplasms.